Scholars Central

Conference abstractPublished 8 Aug 2016

Zerumbone modulation of the beta-catenin-TCF4 binding to induce apoptosis in cancer cells

Authors: Ayesha Fatima

Pharmacist, Malaysia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Wnt-beta catenin pathway has been explored in several cancers. Aberration in the beta catenin inhibitory complex is thought to be the major cause for its uninhibited nuclear translocation and proliferation of cancer cells. Zerumbone, a sesquiterpene from Zingiber zerumbet Smith., has shown an excellent effectiveness as anticancer by inducing apoptosis in a time-dependent and concentration-dependent manner. Using computational techniques, this study aimed to predict the targets of Zerumbone in the pathway and to understand their binding mechanism. Our results showed that beta catenin-TCF4 complex could be the targets of Zerumbone. The binding free energy of beta catenin-TCF4 complexes from docking and molecular mechanics are -80 kcal/mol and -11. 9 kcal/mol, respectively. QM/MM method was used to estimate the effect of binding dynamics in the critical binding area between beta catenin-TCF4. It was found that the binding free energy was -29 kcal/mol in the QM region. From the results of steered molecular dynamics, the force required to pull the TCF4 peptide from the beta catenin in the presence of Zerumbone was almost similar, however it took slightly longer time to pull the chain. Wet laboratory results also confirmed that Zerumbone inhibits beta catenin nuclear translocation in HEPG2 cell line, however same results were not observed for MCF7. Hence, Zerumbone can strongly modulate the binding of beta catenin with TCF4 in a time-dependent manner thus altering the cellular pool of cell proliferating proteins. Further analysis still requires to unveil the mechanisms of the inhibition process of beta catenin and TCF4-DNA complex.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ayesha Fatima”